Filter posts

Insurer Shifting Blame for Rising Premiums

According to a new report from Chad Terhune with Kaiser Health News, insurance giant Anthem …

New Infographic: A Response to “A Better Deal” on Drug Pricing

The United States is the global leader in biomedical innovation, discovering more new cures than …

Biotech Industry Making Strides In Race to Beat Prostate Cancer

As CEO of a global organization, I’m often on the run. To maintain my stamina, …

JAMA Study Misses the Mark on Cancer R&D Costs & Profitability

Yesterday, JAMA Internal Medicine published a new paper purporting to estimate the R&D expense associated …

Expanded Access – It Continues to Make Headlines

The recent Senate passage of S. 204, the Trickett Wendler, Frank Mongiello, and Jordan McLinn …

ICYMI: Drug Pricing Bill Is Bad for Business, Patients

Researchers and biotech leaders continue to discover new cures and treatments that are making a …

Vaccines Play Key Role in Curbing Antimicrobial Resistance

Antimicrobial resistance (AMR) is one of the greatest public health threats facing the global community …

If It Isn’t Broke …

Congress created the Medicare Part D prescription drug program in 2003, and for more than …

The Benefits of Immunization

In today’s Philadelphia Inquirer, BIO President & CEO Jim Greenwood authored an op-ed for National …

Three Encouraging Steps on Prescription Drug Costs

It’s a refrain you hear often in the news: Drug costs are soaring and nothing …